Sandell Asset Management Corp.

Holdings History for Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX)

Symbol: PCRX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2020			-1.5%	$0	0	-140,000	-100%	$21.45	Q1 2020
31 Dec 2019		1.5%	0%	$6,342,000	140,000	0		$45.30	Q4 2019
31 Dec 2019	put		-1.9%	$0	0	-25,000	-100%	$21.45	Q4 2019
30 Sep 2019		2.2%	+0.16%	$5,330,000	140,000	+10,100	+7.8%	$38.07	Q3 2019
30 Sep 2019	put	1.9%	+1.9%	$952,000	25,000	+25,000	NEW	$38.08	Q3 2019
30 Jun 2019		0.67%	0%	$5,649,000	129,900	0		$43.49	Q2 2019
30 Jun 2019	put		-1.9%	$0	0	-30,000	-100%	$21.45	Q2 2019
31 Mar 2019		0.98%	-0.16%	$4,944,000	129,900	-21,700	-14%	$38.06	Q1 2019
31 Mar 2019	put	1.9%	+1.9%	$1,142,000	30,000	+30,000	NEW	$38.07	Q1 2019
31 Dec 2018		1.6%	-0.44%	$6,522,000	151,600	-41,500	-21%	$43.02	Q4 2018
31 Dec 2018	put		-0.42%	$0	0	-50,000	-100%	$21.45	Q4 2018
30 Sep 2018		1.3%	0%	$9,491,000	193,100	0		$49.15	Q3 2018
30 Sep 2018	put	0.42%	-0.79%	$2,458,000	50,000	-95,000	-66%	$49.16	Q3 2018
30 Jun 2018		1%	0%	$6,189,000	193,100	0		$32.05	Q2 2018
30 Jun 2018	put	0.42%	-0.12%	$4,647,000	145,000	-42,500	-23%	$32.05	Q2 2018
31 Mar 2018		0.89%	-0.85%	$6,015,000	193,100	-183,000	-49%	$31.15	Q1 2018
31 Mar 2018	put	2.6%	+2.6%	$5,841,000	187,500	+187,500	NEW	$31.15	Q1 2018
31 Dec 2017		2.7%	0%	$17,169,000	376,100	0		$45.65	Q4 2017
31 Dec 2017	call		-4.4%	$0	0	-180,000	-100%	$21.45	Q4 2017
30 Sep 2017		2%	+1.7%	$14,123,000	376,100	+328,500	+690%	$37.55	Q3 2017
30 Sep 2017	call	4.4%	+4.4%	$6,759,000	180,000	+180,000	NEW	$37.55	Q3 2017
30 Jun 2017		0.72%	+0.72%	$2,271,000	47,600	+47,600	NEW	$47.71	Q2 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.